Neogen Corporation Inventory, Work in Process, Net of Reserves
Neogen Corporation (NEOG) had Inventory, Work in Process, Net of Reserves of $8.00 million as of 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryWorkInProcessNetOfReserves · last filed 2026-07-30
- 2026-05-31: Inventory, Work in Process, Net of Reserves $8.00M.
- 2025-05-31: Inventory, Work in Process, Net of Reserves $11.20M; Inventory, Work in Process, Net of Reserves as first filed $11.23M.
- 2024-05-31: Inventory, Work in Process, Net of Reserves $10.99M.
- 2024-02-29: Inventory, Work in Process, Net of Reserves $11.39M.
| Period end | Inventory, Work in Process, Net of Reserves | Inventory, Work in Process, Net of Reserves as first filed |
|---|---|---|
| 2026-05-31 | $8.00M 10-K · filed 2026-07-30 | |
| 2025-05-31 | $11.20M 10-K · filed 2026-07-30 | $11.23M 10-K · filed 2025-07-30 |
| 2024-05-31 | $10.99M 10-K · filed 2025-07-30 | |
| 2024-02-29 | $11.39M 10-Q · filed 2024-04-09 | |
| 2023-11-30 | $6.64M 10-Q · filed 2024-01-09 | |
| 2023-08-31 | $6.01M 10-Q · filed 2023-10-10 | |
| 2023-05-31 | $5.37M 10-K · filed 2024-07-30 | $5.37M 10-K · filed 2023-08-15 |
| 2023-02-28 | $7.05M 10-Q · filed 2023-04-04 | |
| 2022-11-30 | $6.01M 10-Q · filed 2023-01-09 | |
| 2022-08-31 | $6.24M 10-Q · filed 2022-09-30 | |
| 2022-05-31 | $6.39M 10-K · filed 2023-08-15 | |
| 2022-02-28 | $6.31M 10-Q · filed 2022-04-01 | |
| 2021-11-30 | $6.30M 10-Q · filed 2021-12-30 | |
| 2021-08-31 | $6.70M 10-Q · filed 2021-09-30 | |
| 2021-05-31 | $6.41M 10-K · filed 2022-07-27 | |
| 2021-02-28 | $7.41M 10-Q · filed 2021-03-31 | |
| 2020-11-30 | $6.02M 10-Q · filed 2020-12-29 | |
| 2020-08-31 | $6.32M 10-Q · filed 2020-09-30 | |
| 2020-05-31 | $6.89M 10-K · filed 2021-07-30 | |
| 2020-02-29 | $5.40M 10-Q · filed 2020-04-03 | |
| 2019-11-30 | $6.08M 10-Q · filed 2019-12-27 | |
| 2019-08-31 | $5.90M 10-Q · filed 2019-09-26 | |
| 2019-05-31 | $5.58M 10-K · filed 2020-07-30 | |
| 2019-02-28 | $6.76M 10-Q · filed 2019-03-29 | |
| 2018-11-30 | $7.60M 10-Q · filed 2018-12-28 | |
| 2018-08-31 | $6.66M 10-Q · filed 2018-10-05 | |
| 2018-05-31 | $5.99M 10-K · filed 2019-07-30 | |
| 2018-02-28 | $6.23M 10-Q · filed 2018-03-29 | |
| 2017-11-30 | $4.96M 10-Q · filed 2018-01-05 | |
| 2017-08-31 | $5.18M 10-Q · filed 2017-09-29 | |
| 2017-05-31 | $4.83M 10-K · filed 2018-07-27 | |
| 2017-02-28 | $5.59M 10-Q · filed 2017-03-31 | |
| 2016-11-30 | $5.59M 10-Q · filed 2016-12-29 | |
| 2016-08-31 | $5.17M 10-Q · filed 2016-09-30 | |
| 2016-05-31 | $4.50M 10-K · filed 2017-07-28 | |
| 2016-02-29 | $5.02M 10-Q · filed 2016-03-31 | |
| 2015-11-30 | $4.22M 10-Q · filed 2016-01-08 | |
| 2015-08-31 | $4.03M 10-Q · filed 2015-09-30 | |
| 2015-05-31 | $3.97M 10-K · filed 2016-07-29 | |
| 2015-02-28 | $4.36M 10-Q · filed 2015-04-01 | |
| 2014-11-30 | $4.47M 10-Q · filed 2014-12-30 | |
| 2014-08-31 | $4.21M 10-Q · filed 2014-09-30 | |
| 2014-05-31 | $3.68M 10-K · filed 2015-07-30 | |
| 2014-02-28 | $4.00M 10-Q · filed 2014-04-04 | |
| 2013-11-30 | $3.94M 10-Q · filed 2014-01-09 | |
| 2013-08-31 | $3.81M 10-Q · filed 2013-09-30 | |
| 2013-05-31 | $3.58M 10-K · filed 2014-07-30 | |
| 2012-05-31 | $2.11M 10-K · filed 2013-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |